Literature DB >> 18218611

Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A), and stimulates Il1a transcription in rat Sertoli cells.

Joseph S Tash1, Ramappa Chakrasali, Sudhakar R Jakkaraj, Jennifer Hughes, S Kendall Smith, Kaori Hornbaker, Leslie L Heckert, Sedide B Ozturk, M Kyle Hadden, Terri Goss Kinzy, Brian S J Blagg, Gunda I Georg.   

Abstract

Gamendazole was recently identified as an orally active antispermatogenic compound with antifertility effects. The cellular mechanism(s) through which these effects occur and the molecular target(s) of gamendazole action are currently unknown. Gamendazole was recently designed as a potent orally active antispermatogenic male contraceptive agent. Here, we report the identification of binding targets and propose a testable mechanism of action for this antispermatogenic agent. Both HSP90AB1 (previously known as HSP90beta [heat shock 90-kDa protein 1, beta]) and EEF1A1 (previously known as eEF1A [eukaryotic translation elongation factor 1 alpha 1]) were identified as binding targets by biotinylated gamendazole (BT-GMZ) affinity purification from testis, Sertoli cells, and ID8 ovarian cancer cells; identification was confirmed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and Western blot analysis. BT-GMZ bound to purified yeast HSP82 (homologue to mammalian HSP90AB1) and EEF1A1, but not to TEF3 or HBS1, and was competed by unlabeled gamendazole. However, gamendazole did not inhibit nucleotide binding by EEF1A1. Gamendazole binding to purified Saccharomyces cerevisiae HSP82 inhibited luciferase refolding and was not competed by the HSP90 drugs geldanamycin or novobiocin analogue, KU-1. Gamendazole elicited degradation of the HSP90-dependent client proteins AKT1 and ERBB2 and had an antiproliferative effect in MCF-7 cells without inducing HSP90. These data suggest that gamendazole may represent a new class of selective HSP90AB1 and EEF1A1 inhibitors. Testis gene microarray analysis from gamendazole-treated rats showed a marked, rapid increase in three interleukin 1 genes and Nfkbia (NF-kappaB inhibitor alpha) 4 h after oral administration. A spike in II1a transcription was confirmed by RT-PCR in primary Sertoli cells 60 min after exposure to 100 nM gamendazole, demonstrating that Sertoli cells are a target. AKT1, NFKB, and interleukin 1 are known regulators of the Sertoli cell-spermatid junctional complexes. A current model for gamendazole action posits that this pathway links interaction with HSP90AB1 and EEF1A1 to the loss of spermatids and resulting infertility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218611     DOI: 10.1095/biolreprod.107.062679

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  39 in total

1.  Testin and actin are key molecular targets of adjudin, an anti-spermatogenic agent, in the testis.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-04

2.  The biology of spermatogenesis: the past, present and future.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

Review 3.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

4.  Male contraception: Where do we go from here?

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Spermatogenesis       Date:  2011-10-01

Review 5.  Adjudin--A Male Contraceptive with Other Biological Activities.

Authors:  Yan-Ho Cheng; Weiliang Xia; Elissa W P Wong; Qian R Xie; Jiaxiang Shao; Tengyuan Liu; Yizhou Quan; Tingting Zhang; Xiao Yang; Keyi Geng; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2015

6.  Eukaryotic Elongation Factor 2 (eEF2) is a Potential Biomarker of Prostate Cancer.

Authors:  Xuefeng Zhang; Linkun Hu; Mingzhan Du; Xuedong Wei; Jun Zhang; Yu Hui; Cheng Chen; Gang Li; Jianquan Hou
Journal:  Pathol Oncol Res       Date:  2017-09-14       Impact factor: 3.201

7.  Unprecedented rearrangement of 2-(2-aminoethyl)-1-aryl-3,4-dihydropyrazino[1,2-b]indazole-2-ium 6-oxides to 2,3-dihydro-1H-imidazo[1,2-b]indazoles.

Authors:  Jan Kocí; Allen G Oliver; Viktor Krchnák
Journal:  J Org Chem       Date:  2010-01-15       Impact factor: 4.354

8.  Inflammatory mediators: Parallels between cancer biology and stem cell therapy.

Authors:  Shyam A Patel; Andrew C Heinrich; Bobby Y Reddy; Pranela Rameshwar
Journal:  J Inflamm Res       Date:  2009-01-01

9.  Translation elongation factor 1A facilitates the assembly of the tombusvirus replicase and stimulates minus-strand synthesis.

Authors:  Zhenghe Li; Judit Pogany; Steven Tupman; Anthony M Esposito; Terri Goss Kinzy; Peter D Nagy
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

Review 10.  Non-hormonal male contraception: A review and development of an Eppin based contraceptive.

Authors:  Michael G O'Rand; Erick J R Silva; Katherine G Hamil
Journal:  Pharmacol Ther       Date:  2015-11-22       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.